Bu sayfada
01ZBH fiyat
02Anlık Görüntü
03Grafik
04Hisse bölünmeleri
05Hakkında
06Performans
07Değerleme ve oranlar
13Temettüler
14Kazançlar
15Tüm Temeller
16Finansal Tablolar
17Kurumsal Sahipler (13F)
18Aktivistler ve %5+ sahipler
19Şirket yöneticileri
20ETF sahipliği
21Konsensüs
22Akranlar
23Haberler
25İşlem Sinyalleri
26Metriklerim
ZBH Zimmer Biomet Holdings, Inc. Common Stock
NYSE · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$88,29
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$79,1252 haftanın en düşüğü
$106,8852 haftanın en yükseği
Piyasa Değeri (MRQ)
$28.20B
P/E (TTM)
21.4
Hisse Başına Kâr (TTM)
$4.12
Gelir (TTM)
$8.51B
rozetleriniz
52 Haftlık Aralık
$79–$107
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$108
P/E
21.4
ROE
6.4%
Net Kâr Marjı
9.5%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ZBH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$88.29
Piyasa Değeri (MRQ)
$28.20B
P/E (TTM)
21.4
Hisse Başına Kâr (TTM)
$4.12
Gelir (TTM)
$8.51B
Temettü Verimi
0.67%
ROE (TTM)
6.4%
D/E Borç/Özsermaye (MRQ)
0.6
52 Haftlık Aralık
$79–$107
ZBH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 01 Mart 2022 | 103-for-100 | İleri |
Zimmer Biomet Holdings, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. (ExtraOrtho). In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.
History
Zimmer Biomet was established in 1927 by Justin O. Zimmer (1884–1951) in Warsaw, Indiana.
On April 24, 2014, it was announced that Zimmer had agreed to purchase Biomet Inc. for $13.4 billion. In October 2014, however, it was announced that the EU's antitrust regulators had opened an extensive investigation into Zimmer's bid for Biomet due to concern that it would substantially lessen competition in certain markets. In March 2016, European Commission (“EC”) conditionally cleared Zimmer's proposed acquisition of Biomet, Inc. and on June 24, 2015, Zimmer completed its acquisition of Biomet forming Zimmer Biomet Holdings.
In October 2014, the company announced it would acquire ETEX Holdings, Inc.
In March 2016, Zimmer Biomet announced it would acquire Ortho Transmission, LLC. The company also announced it would acquire sports medicine company, Cayenne Medical, Inc. Later in the same year the company acquired medical device manufacturer, LDR Holding Corporation for $37 per share ($1 billion in total), merging it into their Spine division. In July, the company acquired French surgical robotics company Medtech. In August, the company announced it was acquiring Delaware-based CD Diagnostics, a diagnostics company developing immunoassays and biomarker testing. In September, Zimmer announced the acquisition of Clinical Graphics, B.V.
The Justin Zimmer House in Warsaw is listed on the National Register of Historic Places.
In January 2023, the company announced its intention to acquire Embody, Inc. for $155 million (plus a potential $120 million in milestones).
In August 2024, Zimmer Biomet announced plans to acquire OrthoGrid Systems, an AI surgical guidance company, in order to expand its market share in hip replacement procedures.
In 2026, Zimmer Biomet acquired the iovera pain therapy business from Pacira BioSciences Inc. for $140 million.
Products
Zimmer designs, develops, manufactures and markets orthopedics products, including knee, hip, shoulder, elbow, foot and ankle artificial joints and dental prostheses. In 2024, Zimmer introduced the ROSA Shoulder, said to be the world's first robotic surgery system for shoulder replacement, and the fourth application for the company's ROSA Robotics portfolio, which includes the ROSA Knee System for total knee arthroplasty and ROSA Hip System for total hip replacement. Zimmer has operations in more than 40 countries around the world (US, Australia, Austria, Belgium, Canada, China, Czech Republic, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Latin America, Netherlands, Brasil, Poland, Portugal, Russia, South Africa, Spain etc.) and sells products in more than 100 countries.
Acquisition history
The following is an illustration of the company's major mergers, acquisitions and historical predecessors:
Company data
Zimmer's 2023 sales were approximately $7.4 billion. The company has approximately 18,000 employees worldwide.
Leadership
Raymond Elliott was president and CEO from August 2001 to May 2007.
David C. Dvorak, was president and CEO from May 1, 2007, to July 11, 2017.
Dan Florin, Interim President and CEO from July 11, 2017, to December 19, 2017.
Bryan C. Hanson, President and CEO from December 19, 2017 to August 22, 2023.
Ivan Tornos, President and CEO from August 22, 2023, to present.
Recognition
In 2016, the company was recognized on the Fortune 500 list for the first time, ranking in position #431. As of 2026, the company is ranked 463rd on the list.
Criticism
During the 2022 Russian invasion of Ukraine, Zimmer Biomet continued to sell to the Russian market. Research from Yale University updated on April 28, 2022, identifying how companies were reacting to Russia's invasion identified Zimmer Biomet as continuing business-as-usual in Russia: companies defying demands for exit/reduction of activities.
Public-private engagement
Activism
Zimmer Biomet is a corporate partner of Human Rights Campaign, a large LGBT advocacy organization.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealth Care
endüstriHealth Care
çalışanlar17.000
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$8.23B2016-12-31 → 2025-12-31
Hisse Başına Kâr$3.552016-12-31 → 2025-12-31
Serbest Nakit Akışı$1.47B2016-12-31 → 2025-12-31
Net kar marjı9.5%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ZBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 21.45Y ort. ≈50.9 | ≈50.9 | 28.6 | Düşük değerli | |
| F/S (TTM) | 3.35Y ort. ≈4.9 | ≈4.9 | 4.4 | Düşük değerli | |
| F/D (MRQ) | 2.25Y ort. ≈2.9 | ≈2.9 | 4.7 | Düşük değerli | |
| EV / EBITDA | 16.05Y ort. ≈21.1 | ≈21.1 | 17.3 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 18.55Y ort. ≈27.7 | ≈27.7 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 16.25Y ort. ≈23.8 | ≈23.8 | 21.9 | Düşük değerli | |
| EV / Revenue (EV / Gelir) | 4.35Y ort. ≈5.7 | ≈5.7 | · | · | |
| EV / FCF | 23.85Y ort. ≈32.2 | ≈32.2 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 3.5 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ZBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 14.2%5Y ort. ≈13.5% | ≈13.5% | 15.6% | Aynı seviyede | |
| FAVÖK Marjı (TTM) | 27.2%5Y ort. ≈26.7% | ≈26.7% | 15.6% | Aynı seviyede | |
| Vergi Öncesi Kar Marjı (TTM) | 11.0%5Y ort. ≈9.8% | ≈9.8% | 14.0% | Zayıf | |
| Net Kâr Marjı (TTM) | 9.5%5Y ort. ≈8.5% | ≈8.5% | 11.2% | Zayıf | |
| ROA (TTM) | 3.5%5Y ort. ≈3.0% | ≈3.0% | 8.0% | Zayıf | |
| ROE (TTM) | 6.4%5Y ort. ≈5.3% | ≈5.3% | 14.8% | Zayıf | |
| ROIC | 4.6%5Y ort. ≈4.8% | ≈4.8% | 10.9% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ZBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.65Y ort. ≈0.5 | ≈0.5 | 0.2 | Yüksek borç | |
| Cari Oran (MRQ) | 1.75Y ort. ≈1.8 | ≈1.8 | 1.8 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.95Y ort. ≈0.7 | ≈0.7 | 0.9 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.55Y ort. ≈0.4 | ≈0.4 | 0.5 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ZBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 7.2%5Y ort. ≈6.1% | ≈6.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 5.9%5Y ort. ≈5.4% | ≈5.4% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 6.1% | · | · | · | |
| EPS YoY (EPS YB) | -19.9%5Y ort. ≈68.0% | ≈68.0% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -22.0%5Y ort. ≈66.6% | ≈66.6% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 47.8% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 45.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ZBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.45Y ort. ≈0.3 | ≈0.3 | 0.6 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 1.15Y ort. ≈1.0 | ≈1.0 | 2.4 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 5.25Y ort. ≈5.3 | ≈5.3 | 6.2 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$484.2K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi0.67%
Temettü Ödeme Oranı27.0%
Yıllıklaştırılmış Ödeme≈$0.96
5 Yıllık Temettü CAGR≈0.59%
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Haz 25, 2026 | $0,24 | USD | ≈1.1% |
| Mar 31, 2026 | $0,24 | USD | ≈1.1% |
| Ara 30, 2025 | $0,24 | USD | ≈1.1% |
| Eyl 30, 2025 | $0,24 | USD | ≈0.97% |
| Haz 26, 2025 | $0,24 | USD | ≈1.0% |
| Mar 31, 2025 | $0,24 | USD | ≈0.85% |
| Ara 30, 2024 | $0,24 | USD | ≈0.91% |
| Eyl 30, 2024 | $0,24 | USD | ≈0.89% |
| Haz 26, 2024 | $0,24 | USD | ≈0.89% |
| Mar 27, 2024 | $0,24 | USD | ≈0.72% |
| Ara 26, 2023 | $0,24 | USD | ≈0.79% |
| Eyl 28, 2023 | $0,24 | USD | ≈0.85% |
| Haz 23, 2023 | $0,24 | USD | ≈0.67% |
| Mar 28, 2023 | $0,24 | USD | ≈0.76% |
| Ara 23, 2022 | $0,24 | USD | ≈0.76% |
| Eyl 29, 2022 | $0,24 | USD | ≈0.89% |
| Haz 24, 2022 | $0,24 | USD | ≈0.87% |
| Mar 28, 2022 | $0,24 | USD | ≈0.75% |
| Ara 27, 2021 | $0,23 | USD | ≈0.75% |
| Eyl 29, 2021 | $0,23 | USD | ≈0.64% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
3.0%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 5, 2026 | $2.07 | $2.03 | 2.0% |
| 31 Mart 2026 | $2.09 | $1.88 | 11.0% | |
| 31 Aralık 2025 | $2.42 | $2.42 | 0.00% | |
| 30 Eylül 2025 | $1.90 | $1.89 | 0.73% | |
| 30 Haziran 2025 | $2.07 | $2.00 | 3.3% | |
| 31 Mart 2025 | $1.81 | $1.79 | 1.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Cost of Revenue | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B | $2.25B | $2.27B | $2.13B | $2.38B | $1.80B | $1.24B | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $3.42B | |
| SG&A Expense | $3.26B | $2.93B | $2.84B | $2.76B | $2.84B | $2.71B | $3.34B | $3.38B | $3.10B | $2.94B | $2.28B | $1.75B | |
| Operating Expenses | $7.13B | $6.39B | $6.12B | $6.24B | $5.97B | $6.04B | $6.84B | $7.90B | $7.00B | $6.85B | $5.53B | $3.64B | |
| Operating Income | $1.10B | $1.29B | $1.28B | $696M | $860M | $83M | $1.14B | $34M | $799M | $821M | $467M | $1.04B | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $3M | $9M | $12M | |
| Other Non-op | $26M | $-31M | $-9M | $-128M | $12M | $24M | $-5M | $-16M | $-9M | $-66M | $-37M | $-47M | |
| Pretax Income | $831M | $1.04B | $1.07B | $404M | $499M | $-105M | $906M | $-271M | $465M | $400M | $153M | $939M | |
| Income Tax | $126M | $131M | $42M | $112M | $54M | $-96M | $-226M | $108M | $-1.35B | $95M | $7M | $220M | |
| Net Income | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| EPS (Basic) | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | $-0.67 | $5.52 | $-1.86 | $8.98 | $1.53 | $0.78 | $4.26 | |
| EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 | |
| Shares (Basic) | 198,000,000 | 203,100,000 | 208,700,000 | 209,600,000 | 208,600,000 | 207,000,000 | 205,100,000 | 203,500,000 | 201,900,000 | 200,000,000 | 187,400,000 | 169,000,000 | |
| Shares (Diluted) | 198,700,000 | 203,900,000 | 209,700,000 | 210,300,000 | 210,400,000 | 207,000,000 | 206,700,000 | 203,500,000 | 203,700,000 | 202,400,000 | 189,800,000 | 171,700,000 | |
| EBITDA | $2.19B | $2.28B | $2.23B | $1.62B | $1.85B | $945M | $2.14B | $1.07B | $1.87B | $1.87B | $1.18B | $1.41B |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $592M | $526M | $416M | $376M | $378M | $802M | $618M | $543M | $524M | $634M | $1.46B | $1.08B | |
| Receivables | $1.70B | $1.48B | $1.44B | $1.38B | $1.26B | $1.45B | $1.36B | $1.28B | $1.54B | $1.60B | $1.45B | $912M | |
| Inventory | $2.29B | $2.24B | $2.39B | $2.15B | $2.15B | $2.45B | $2.38B | $2.26B | $2.07B | $1.96B | $2.25B | $1.19B | |
| Prepaid Expense | $537M | $430M | $366M | $523M | $271M | $169M | $357M | $352M | $428M | $466M | $529M | $317M | |
| Current Assets | $5.12B | $4.67B | $4.61B | $4.43B | $4.88B | $5.08B | $4.72B | $4.43B | $4.56B | $4.66B | $5.85B | $4.31B | |
| PP&E (Net) | $2.21B | $2.05B | $2.06B | $1.87B | $1.84B | $2.05B | $2.08B | $2.02B | $2.04B | $2.04B | $2.06B | $1.29B | |
| PP&E (Gross) | $7.26B | $6.69B | $6.77B | $6.46B | $6.14B | $6.32B | $5.92B | $5.44B | $5.08B | $4.67B | $4.43B | $3.41B | |
| Accum. Depreciation | $5.05B | $4.64B | $4.71B | $4.59B | $4.30B | $4.28B | $3.84B | $3.42B | $3.05B | $2.63B | $2.37B | $2.12B | |
| Goodwill | $9.95B | $8.95B | $8.82B | $8.58B | $8.92B | $8.98B | $9.60B | $9.59B | $10.67B | $10.64B | $9.93B | $2.51B | |
| Intangibles | $4.72B | $4.60B | $4.86B | $5.06B | $5.53B | $7.06B | $7.26B | $7.68B | $8.35B | $8.79B | $8.75B | $604M | |
| Other Non-current Assets | $1.10B | $1.10B | $1.15B | $1.12B | $1.00B | $969M | $980M | $405M | $389M | $554M | $564M | $942M | |
| Total Assets | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Accounts Payable | $303M | $195M | $411M | $354M | $306M | $330M | $401M | $363M | $330M | $364M | $285M | $145M | |
| Accrued Liabilities | $834M | $706M | $804M | $582M | $536M | $873M | $778M | $671M | $775M | $789M | $726M | $351M | |
| Current Liabilities | $2.58B | $2.45B | $2.86B | $2.36B | $3.47B | $2.56B | $3.44B | $2.42B | $3.07B | $2.38B | $1.62B | $1.02B | |
| Capital Leases | $176M | $190M | $174M | $167M | $175M | $218M | $216M | · | · | · | · | · | |
| Deferred Tax | $244M | $352M | $358M | $475M | $558M | $790M | $840M | $1000M | $1.10B | $3.03B | $3.15B | $46M | |
| Other Non-current Liabilities | $626M | $744M | $926M | $633M | $548M | $656M | $558M | $350M | $446M | $463M | $1.01B | $611M | |
| Total Liabilities | $10.39B | $8.89B | $9.01B | $9.04B | $10.79B | $12.22B | $12.25B | $12.85B | $14.28B | $17.01B | $17.27B | $3.11B | |
| Long-term Debt | $7.52B | $6.20B | $5.77B | $5.70B | $1.00B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | · | · | |
| Total Debt | $7.52B | $6.20B | $5.77B | $5.70B | $7.07B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | $11.56B | $1.43B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $11.61B | $11.10B | $10.38B | $9.56B | $10.29B | $10.09B | $10.43B | $9.49B | $10.02B | $8.47B | $8.35B | $8.36B | |
| Treasury Stock | $8.89B | $8.41B | $7.56B | $6.87B | $6.72B | $6.72B | $6.72B | $6.72B | $6.72B | $6.74B | $6.33B | $6.18B | |
| AOCI | $-206M | $-263M | $-191M | $-179M | $-232M | $-298M | $-242M | $-187M | $-83M | $-434M | $-329M | $38M | |
| Stockholders' Equity | $12.70B | $12.47B | $12.48B | $12.02B | $12.66B | $12.19B | $12.39B | $11.27B | $11.74B | $9.67B | $9.89B | $6.55B | |
| Liabilities + Equity | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Shares Outstanding | 318,700,000 | 317,500,000 | 316,200,000 | 313,800,000 | 312,800,000 | 311,400,000 | 309,900,000 | 307,900,000 | 306,500,000 | 304,700,000 | 302,700,000 | 268,400,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.09B | $996M | $952M | $926M | $938M | $898M | $1.01B | $1.04B | $1.06B | $1.04B | $712M | $376M | |
| Stock-based Comp | $90M | $101M | $100M | $105M | $76M | $74M | $84M | $66M | $54M | $57M | $46M | $49M | |
| Deferred Tax | $-87M | $-48M | $-96M | $-64M | $-102M | $39M | $-539M | $13M | $-1.78B | $-153M | $-164M | $-90M | |
| Amort. of Intangibles | $666M | $592M | $562M | $527M | $530M | $512M | $584M | $596M | $604M | $566M | $337M | $92M | |
| Restructuring | · | · | · | · | $32M | · | · | · | $17M | $91M | $196M | · | |
| Other Non-cash | $-105M | $-454M | $-398M | $158M | $95M | $219M | $-98M | $1.01B | $428M | $383M | $75M | $-8M | |
| Operating Cash Flow | $1.70B | $1.50B | $1.58B | $1.36B | $1.40B | $1.08B | $1.59B | $1.75B | $1.58B | $1.63B | $850M | $1.06B | |
| CapEx | $224M | $204M | $291M | $188M | $144M | $112M | $207M | $163M | $156M | $185M | $168M | $145M | |
| Investing Cash Flow | $-1.98B | $-888M | $-779M | · | $-504M | $-614M | $-729M | $-417M | $-511M | $-1.69B | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $750M | $3.00B | · | |
| Net Debt Issued | · | · | · | · | · | · | · | $-1.43B | $-940M | $-50M | $2.50B | · | |
| Stock Repurchased | $487M | $868M | $692M | $126M | · | · | · | · | · | $416M | $150M | $401M | |
| Net Stock Activity | $-487M | $-868M | $-692M | $-126M | · | · | · | · | · | $-416M | $-150M | $-400M | |
| Dividends Paid | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M | |
| Financing Cash Flow | $326M | $-484M | $-764M | · | $-1.31B | $-422M | $-780M | $-1.30B | $-1.21B | $-743M | · | · | |
| Net Change in Cash | $66M | $110M | $40M | $-103M | $-324M | $184M | $75M | $18M | $-110M | $-825M | $376M | $3M | |
| Taxes Paid | $377M | $328M | $215M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B | $1.09B | $1.38B | $1.58B | $1.43B | $1.45B | $649M | $908M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 73.3% | |
| Operating Margin | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% | -1.2% | 14.2% | 0.43% | 10.3% | 10.8% | 7.8% | 22.1% | |
| Net Margin | 8.6% | 11.8% | 13.9% | 3.3% | 5.1% | -2.0% | 14.2% | -4.8% | 23.2% | 4.0% | 2.5% | 15.4% | |
| Pretax Margin | 10.1% | 13.5% | 14.4% | 5.8% | 5.3% | -3.9% | 11.3% | -3.4% | 5.9% | 5.2% | 2.5% | 20.2% | |
| EBITDA Margin | 26.6% | 29.7% | 30.1% | 23.4% | 23.6% | 13.5% | 26.9% | 13.5% | 23.9% | 24.3% | 19.7% | 30.2% | |
| ROA | 3.2% | 4.2% | 4.8% | 1.0% | 1.7% | -0.57% | 4.6% | -1.5% | 6.9% | 1.1% | 0.54% | 7.5% | |
| ROE | 5.6% | 7.2% | 8.4% | 1.9% | 3.2% | -1.1% | 9.6% | -3.3% | 17.0% | 3.1% | 1.5% | 11.2% | |
| ROIC | 4.6% | 6.0% | 6.7% | 2.8% | 3.8% | -0.22% | 6.9% | 0.23% | 14.4% | 3.0% | 2.1% | 9.9% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 | 2.0 | 1.4 | 1.8 | 1.5 | 2.0 | 3.6 | 4.1 | |
| Quick Ratio | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 | 0.9 | 0.6 | 0.8 | 0.7 | 0.9 | 1.8 | 1.9 | |
| Debt / Equity | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 1.2 | 0.2 | |
| LT Debt / Equity | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.5 | 0.7 | 0.8 | 1.1 | 1.2 | 0.2 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.5 | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 | 1.1 | 1.1 | 1.1 | 0.8 | 1.1 | |
| Receivables Turnover | 5.2 | 5.3 | 5.2 | 5.3 | 5.5 | 5.0 | 6.0 | 5.6 | 5.0 | 5.0 | 5.1 | 5.1 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.84 | $39.27 | $39.47 | $38.31 | $40.48 | $39.16 | $39.97 | $36.61 | $38.29 | $31.73 | $32.67 | · | |
| Revenue / Share | $41.43 | $37.66 | $35.26 | $33.00 | $37.24 | $33.93 | $38.62 | $38.98 | $38.41 | $37.96 | $31.60 | $27.22 | |
| Cash Flow / Share | $8.54 | $7.35 | $7.54 | $6.45 | $7.13 | $5.82 | $7.67 | $8.59 | $7.77 | $8.06 | $4.30 | $6.13 | |
| Cash / Share | $1.86 | $1.66 | $1.31 | $1.20 | $1.53 | $2.58 | $1.99 | $1.76 | $1.71 | $2.08 | $4.82 | · | |
| Dividend / Share | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.88 | $0.88 | |
| EPS (TTM) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.2% | 3.9% | 6.6% | 1.7% | 11.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.9% | 4.0% | 6.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -19.9% | -9.2% | 343.6% | -42.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 47.8% | 32.4% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -22.0% | -11.7% | 342.5% | -42.4% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 45.0% | 31.1% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -0.84% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Net Income TTM | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| Market Cap | $28.66B | $33.54B | $38.48B | $40.01B | $38.58B | $46.59B | $45.03B | $31.01B | $35.91B | $30.53B | $30.15B | · | |
| Enterprise Value | $35.58B | $39.22B | $43.83B | $45.33B | $45.17B | $53.91B | $52.64B | $39.40B | $45.53B | $41.14B | $40.25B | · | |
| P/E | 25.3 | 23.8 | 24.9 | 115.9 | 64.6 | -223.3 | 26.6 | -54.1 | 13.2 | 66.4 | 129.4 | 26.2 | |
| P/S | 3.5 | 4.4 | 5.2 | 5.8 | 5.7 | 7.6 | 5.6 | 3.9 | 4.6 | 4.0 | 5.0 | · | |
| P/B | 2.3 | 2.7 | 3.1 | 3.3 | 3.0 | 3.8 | 3.6 | 2.8 | 3.1 | 3.2 | 3.0 | · | |
| P / Cash Flow | 16.9 | 22.4 | 24.3 | 29.5 | 25.7 | 38.7 | 28.4 | 17.7 | 22.7 | 18.7 | 36.9 | · | |
| P / FCF | 19.5 | 25.9 | 29.8 | 34.2 | 29.1 | 42.9 | 32.7 | 19.6 | 25.2 | 21.1 | 46.5 | · | |
| EV / EBITDA | 16.2 | 17.2 | 19.7 | 27.9 | 24.4 | 57.1 | 24.6 | 36.7 | 24.3 | 22.1 | 34.1 | · | |
| EV / FCF | 24.2 | 30.3 | 34.0 | 38.8 | 34.0 | 49.6 | 38.2 | 24.9 | 31.9 | 28.4 | 62.0 | · | |
| EV / Revenue | 4.3 | 5.1 | 5.9 | 6.5 | 6.6 | 8.8 | 6.6 | 5.0 | 5.8 | 5.4 | 6.7 | · | |
| Dividend Yield | 0.66% | 0.58% | 0.52% | 0.50% | 0.52% | 0.43% | 0.44% | 0.63% | 0.54% | 0.62% | 0.52% | · | |
| Earnings Yield | 4.0% | 4.2% | 4.0% | 0.86% | 1.6% | -0.45% | 3.8% | -1.8% | 7.6% | 1.5% | 0.77% | 3.8% | |
| Payout Ratio | 27.0% | 21.7% | 19.6% | 87.0% | 49.8% | -142.9% | 17.4% | -51.5% | 10.7% | 61.6% | 106.9% | 20.2% | |
| Annual Payout | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.09B | $2.24B | $2.00B | $2.08B | $1.91B | $2.02B | $1.82B | $1.94B | $1.89B | $1.94B | $1.75B | $1.87B | $1.83B | $1.83B | $1.67B | |
| Cost of Revenue | $636M | $576M | $792M | $559M | $592M | $550M | $587M | $539M | $554M | $512M | $539M | $519M | $526M | $501M | $520M | $488M | |
| SG&A Expense | $899M | $850M | $872M | $811M | $815M | $759M | $747M | $710M | $737M | $736M | $722M | $675M | $726M | $716M | $727M | $655M | |
| Operating Expenses | $1.85B | $1.71B | $2.09B | $1.65B | $1.78B | $1.62B | $1.63B | $1.54B | $1.59B | $1.62B | $1.59B | $1.49B | $1.54B | $1.50B | $1.85B | $1.42B | |
| Operating Income | $326M | $373M | $154M | $351M | $300M | $292M | $389M | $280M | $351M | $266M | $354M | $267M | $330M | $327M | $-28M | $245M | |
| Other Non-op | $2M | $-3M | $15M | $3M | $4M | $3M | $-38M | $5M | $2M | $-100.0K | $-20M | $4M | $-1M | $8M | $-4M | $-25M | |
| Pretax Income | $255M | $301M | $98M | $279M | $225M | $229M | $289M | $230M | $302M | $215M | $284M | $219M | $277M | $287M | $-75M | $178M | |
| Income Tax | $56M | $63M | $-40M | $48M | $71M | $46M | $49M | $-19M | $59M | $42M | $-135M | $56M | $67M | $54M | $55M | $-17M | |
| Net Income | $198M | $238M | $139M | $231M | $153M | $182M | $240M | $249M | $243M | $172M | $419M | $163M | $210M | $232M | $-130M | $194M | |
| EPS (Basic) | $1.03 | $1.22 | $0.70 | $1.17 | $0.77 | $0.92 | $1.20 | $1.23 | $1.18 | $0.84 | $2.02 | $0.78 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| EPS (Diluted) | $1.03 | $1.22 | $0.71 | $1.16 | $0.77 | $0.91 | $1.18 | $1.23 | $1.18 | $0.84 | $2.00 | $0.77 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| Shares (Basic) | 192,200,000 | 195,000,000 | · | 198,100,000 | 197,900,000 | 198,900,000 | · | 202,300,000 | 205,700,000 | 205,200,000 | · | 208,900,000 | 208,600,000 | 209,400,000 | · | 209,800,000 | |
| Shares (Diluted) | 192,800,000 | 195,800,000 | · | 198,800,000 | 198,300,000 | 199,700,000 | · | 203,000,000 | 206,400,000 | 206,200,000 | · | 210,000,000 | 209,900,000 | 210,400,000 | · | 210,300,000 | |
| EBITDA | $326M | $643M | · | $351M | $300M | $547M | · | $280M | $351M | $504M | · | $267M | $330M | $559M | · | $245M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $410M | $424M | $592M | $1.29B | $557M | $1.38B | $526M | $569M | $420M | $393M | · | $292M | $320M | $330M | · | $545M | |
| Receivables | $1.77B | $1.73B | $1.70B | $1.60B | $1.61B | $1.53B | $1.48B | $1.48B | $1.42B | $1.45B | · | $1.34B | $1.37B | $1.38B | · | $1.28B | |
| Inventory | $2.27B | $2.25B | $2.29B | $2.48B | $2.45B | $2.24B | $2.24B | $2.37B | $2.37B | $2.39B | · | $2.32B | $2.28B | $2.24B | · | $2.13B | |
| Prepaid Expense | $647M | $563M | $537M | $460M | $431M | $428M | $430M | $445M | $431M | $404M | · | $416M | $425M | $460M | · | $347M | |
| Current Assets | $5.10B | $4.96B | $5.12B | $5.83B | $5.05B | $5.59B | $4.67B | $4.86B | $4.64B | $4.63B | · | $4.37B | $4.39B | $4.41B | · | $4.53B | |
| PP&E (Net) | $2.24B | $2.21B | $2.21B | $2.19B | $2.18B | $2.06B | $2.05B | $2.11B | $2.10B | $2.09B | · | $2.03B | $1.98B | $1.91B | · | $1.80B | |
| PP&E (Gross) | $7.42B | $7.30B | $7.26B | $7.22B | $7.15B | $6.82B | $6.69B | $6.90B | $6.74B | $6.85B | · | $6.65B | $6.72B | $6.59B | · | $6.34B | |
| Accum. Depreciation | $5.18B | $5.09B | $5.05B | $5.03B | $4.97B | $4.76B | $4.64B | $4.79B | $4.64B | $4.76B | · | $4.61B | $4.74B | $4.69B | · | $4.54B | |
| Goodwill | $9.92B | $9.93B | $9.95B | $9.70B | $9.71B | $8.99B | $8.95B | $8.91B | $8.82B | $8.79B | $8.82B | $8.71B | $8.74B | $8.73B | $8.58B | $8.80B | |
| Intangibles | $4.46B | $4.55B | $4.72B | $4.74B | $4.89B | $4.47B | $4.60B | $4.67B | $4.71B | $4.73B | · | $4.89B | $5.03B | $5.07B | · | $5.14B | |
| Other Non-current Assets | $1.08B | $1.07B | $1.10B | $1.02B | $1.04B | $1.07B | $1.10B | $1.17B | $1.25B | $1.20B | · | $1.21B | $1.16B | $1.12B | · | $1.06B | |
| Total Assets | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Accounts Payable | $352M | $361M | $303M | $315M | $349M | $301M | $195M | $322M | $342M | $370M | · | $320M | $355M | $397M | · | $334M | |
| Accrued Liabilities | · | · | $834M | · | · | · | $706M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.01B | $2.86B | $2.58B | $2.40B | $2.70B | $2.29B | $2.45B | $3.57B | $3.61B | $2.80B | · | $2.07B | $2.23B | $2.34B | · | $2.30B | |
| Capital Leases | · | · | $176M | · | · | · | $190M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $236M | $250M | $244M | · | · | · | $352M | · | · | $370M | · | $465M | $475M | $485M | · | $541M | |
| Other Non-current Liabilities | $639M | $631M | $626M | $806M | $879M | $909M | $744M | $1.03B | $1.21B | $577M | · | $632M | $642M | $637M | · | $609M | |
| Total Liabilities | $10.17B | $10.04B | $10.39B | $10.72B | $10.33B | $9.78B | $8.89B | $9.34B | $8.77B | $8.85B | · | $8.70B | $8.92B | $9.09B | · | $9.08B | |
| Long-term Debt | $7.48B | $7.47B | $7.52B | $8.11B | $7.57B | $7.18B | $6.20B | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Total Debt | $7.48B | $7.47B | · | $8.11B | $7.57B | $7.18B | · | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $11.96B | $11.80B | $11.61B | $11.52B | $11.34B | $11.23B | $11.10B | $10.90B | $10.70B | $10.51B | · | $10.01B | $9.90B | $9.74B | · | $9.74B | |
| Treasury Stock | $9.39B | $9.14B | $8.89B | $8.64B | $8.64B | $8.64B | $8.41B | $8.35B | $7.74B | $7.65B | · | $7.12B | $7.12B | $7.11B | · | $6.72B | |
| AOCI | $-164M | $-190M | $-206M | $-284M | $-284M | $-287M | $-263M | $-202M | $-195M | $-211M | · | $-186M | $-178M | $-178M | · | $-245M | |
| Stockholders' Equity | $12.62B | $12.67B | $12.70B | $12.76B | $12.53B | $12.40B | $12.47B | $12.37B | $12.74B | $12.60B | · | $12.51B | $12.37B | $12.15B | · | $12.24B | |
| Liabilities + Equity | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Shares Outstanding | 319,400,000 | 319,300,000 | 318,700,000 | 318,700,000 | 318,400,000 | 318,400,000 | 317,500,000 | 317,400,000 | 317,200,000 | 317,200,000 | 316,200,000 | 316,000,000 | 315,800,000 | 315,400,000 | 313,800,000 | 313,600,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $271M | $270M | $284M | $284M | $272M | $254M | $264M | $251M | $243M | $239M | $241M | $241M | $238M | $232M | $228M | $231M | |
| Stock-based Comp | $25M | $24M | $24M | $25M | $21M | $20M | $21M | $24M | $26M | $29M | $25M | $16M | $34M | $25M | $27M | $27M | |
| Amort. of Intangibles | $163M | $162M | $178M | $176M | $161M | $151M | $158M | $148M | $144M | $142M | $145M | $145M | $138M | $133M | $132M | $132M | |
| Other Non-cash | · | $-173M | · | · | · | $-73M | · | · | · | $-212M | · | · | · | $-182M | · | · | |
| Operating Cash Flow | $448M | $359M | $517M | $419M | $378M | $383M | $506M | $396M | $369M | $228M | $588M | $338M | $348M | $308M | $244M | $451M | |
| CapEx | $54M | $36M | $75M | $55M | $50M | $45M | $52M | $44M | $53M | $55M | $63M | $84M | $97M | $47M | $63M | $47M | |
| Investing Cash Flow | $-191M | $-159M | $-322M | $-163M | $-1.38B | $-106M | $-291M | $-155M | $-247M | $-195M | $-221M | $-166M | $-243M | $-149M | · | · | |
| Stock Repurchased | $251M | $250M | $250M | $0 | $7M | $230M | $72M | $596M | $86M | $114M | $410M | $0 | $14M | $268M | · | · | |
| Net Stock Activity | · | $-250M | · | · | · | $-230M | · | · | · | $-114M | · | · | · | $-268M | · | · | |
| Dividends Paid | $46M | $47M | $48M | $48M | $48M | $48M | $48M | $49M | $49M | $49M | $50M | $50M | $50M | $50M | $50M | $50M | |
| Financing Cash Flow | $-271M | $-369M | $-897M | $484M | $164M | $575M | $-241M | $-102M | $-92M | $-50M | $-251M | $-196M | $-109M | $-207M | · | · | |
| Net Change in Cash | $-14M | $-168M | $-701M | $736M | $-828M | $859M | $-44M | $149M | $27M | $-23M | $124M | $-28M | $-10M | $-46M | $-170M | $159M | |
| Free Cash Flow | · | $323M | · | · | · | $338M | · | · | · | $173M | · | · | · | $261M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 17.9% | · | 17.5% | 14.4% | 15.3% | · | 15.3% | 18.1% | 14.1% | · | 15.2% | 17.6% | 17.9% | · | 14.7% | |
| Net Margin | 9.1% | 11.4% | · | 11.5% | 7.4% | 9.5% | · | 13.7% | 12.5% | 9.1% | · | 9.3% | 11.2% | 12.7% | · | 11.6% | |
| Pretax Margin | 11.7% | 14.4% | · | 14.0% | 10.8% | 12.0% | · | 12.6% | 15.6% | 11.4% | · | 12.5% | 14.8% | 15.7% | · | 10.6% | |
| EBITDA Margin | 15.0% | 30.8% | · | 17.5% | 14.4% | 28.6% | · | 15.3% | 18.1% | 26.7% | · | 15.2% | 17.6% | 30.5% | · | 14.7% | |
| ROA | 0.87% | 1.1% | · | 1.0% | 0.69% | 0.83% | · | 1.2% | 1.1% | 0.81% | · | 0.76% | 0.98% | 1.1% | · | 0.86% | |
| ROE | 1.6% | 1.9% | · | 1.8% | 1.2% | 1.5% | · | 2.0% | 1.9% | 1.4% | · | 1.3% | 1.7% | 1.9% | · | 1.6% | |
| ROIC | 1.3% | 1.5% | · | 1.4% | 1.0% | 1.2% | · | 1.6% | 1.5% | 1.2% | · | 1.1% | 1.4% | 1.5% | · | 1.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.7 | · | 2.4 | 1.9 | 2.4 | · | 1.4 | 1.3 | 1.7 | · | 2.1 | 2.0 | 1.9 | · | 2.0 | |
| Quick Ratio | 0.7 | 0.8 | · | 1.2 | 0.8 | 1.3 | · | 0.6 | 0.5 | 0.7 | · | 0.8 | 0.8 | 0.7 | · | 0.8 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.4 | · | 1.3 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.52 | $39.69 | · | $40.03 | $39.34 | $38.93 | · | $38.99 | $40.17 | $39.72 | · | $39.59 | $39.18 | $38.52 | · | $39.05 | |
| Revenue / Share | $11.29 | $10.66 | · | $10.07 | $10.48 | $9.56 | · | $8.99 | $9.41 | $9.16 | · | $8.35 | $8.91 | $8.70 | · | $7.94 | |
| Cash Flow / Share | · | $1.84 | · | · | · | $1.92 | · | · | · | $1.11 | · | · | · | $1.46 | · | · | |
| Cash / Share | $1.28 | $1.33 | · | $4.06 | $1.75 | $4.35 | · | $1.79 | $1.32 | $1.24 | · | $0.92 | $1.01 | $1.05 | · | $1.74 | |
| Dividend / Share | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | |
| EPS (TTM) | $4.12 | $3.86 | · | $4.02 | $4.09 | $4.50 | · | $5.25 | $4.79 | $4.61 | · | $2.26 | $2.41 | $2.14 | · | $1.33 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.51B | $8.41B | · | $8.01B | $7.83B | $7.70B | · | $7.60B | $7.52B | $7.45B | · | $7.28B | $7.20B | $7.11B | · | $6.89B | |
| Net Income TTM | $807M | $761M | · | $805M | $823M | $913M | · | $1.08B | $997M | $964M | · | $474M | $506M | $450M | · | $278M | |
| Market Cap | $27.50B | $28.87B | · | $31.39B | $29.04B | $36.04B | · | $34.26B | $34.43B | $41.86B | · | $35.46B | $45.98B | $40.75B | · | $32.79B | |
| Enterprise Value | $34.57B | $35.92B | · | $38.21B | $36.06B | $41.83B | · | $40.15B | $39.84B | $47.27B | · | $40.65B | $51.37B | $46.21B | · | $37.96B | |
| P/E | 20.9 | 23.4 | · | 24.5 | 22.3 | 25.2 | · | 20.6 | 22.7 | 28.6 | · | 49.7 | 60.4 | 60.4 | · | 78.6 | |
| P/S | 3.2 | 3.4 | · | 3.9 | 3.7 | 4.7 | · | 4.5 | 4.6 | 5.6 | · | 4.9 | 6.4 | 5.7 | · | 4.8 | |
| P/B | 2.2 | 2.3 | · | 2.5 | 2.3 | 2.9 | · | 2.8 | 2.7 | 3.3 | · | 2.8 | 3.7 | 3.4 | · | 2.7 | |
| P / Cash Flow | · | 80.3 | · | · | · | 94.1 | · | · | · | 183.6 | · | · | · | 132.4 | · | · | |
| EV / Revenue | 4.1 | 4.3 | · | 4.8 | 4.6 | 5.4 | · | 5.3 | 5.3 | 6.3 | · | 5.6 | 7.1 | 6.5 | · | 5.5 | |
| Dividend Yield | 0.69% | 0.66% | · | 0.61% | 0.66% | 0.54% | · | 0.58% | 0.58% | 0.48% | · | 0.57% | 0.44% | 0.49% | · | 0.61% | |
| Earnings Yield | 4.8% | 4.3% | · | 4.1% | 4.5% | 4.0% | · | 4.9% | 4.4% | 3.5% | · | 2.0% | 1.7% | 1.7% | · | 1.3% | |
| Payout Ratio | · | 19.7% | · | · | · | 26.3% | · | · | · | 28.6% | · | · | · | 21.6% | · | · | |
| Annual Payout | $188M | $189M | · | $191M | $192M | $194M | · | $198M | $199M | $200M | · | $201M | $201M | $201M | · | $201M |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Faaliyet Kâr Marjı % | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% |
| Net Gelir | $705M | $904M | $1.02B | $231M | $402M |
| Seyreltilmiş Hisse Başı Kâr | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
| Cari Oran | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 |
| Cari Oran | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B |
Kurumsal Sahipler (13F) 976 dosya · $18.6B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
976
Tutulan Değer
$18.6B
Yeni pozisyonlar
89
Çıkan pozisyonlar
81
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 89 (-27 önceki Ç'ye göre) | 81 (-21 önceki Ç'ye göre) | 313 (+13 önceki Ç'ye göre) | 303 (+4 önceki Ç'ye göre) | +9.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2.111.657.991 | 23.483.741 | 11,35% | Hisse senetleri |
| Dodge & Cox | $2.076.898.436 | 24.124.735 | 11,17% | Hisse senetleri |
| BlackRock, Inc. | $1.344.282.175 | 15.614.847 | 7,23% | Hisse senetleri |
| HARRIS ASSOCIATES L P | $1.096.616.595 | 12.738.025 | 5,90% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.087.741.726 | 12.634.937 | 5,85% | Hisse senetleri |
| Capital International Investors | $1.048.887.329 | 12.183.614 | 5,64% | Hisse senetleri |
| STATE STREET CORP | $766.342.640 | 8.877.171 | 4,12% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $726.749.999 | 8.441.747 | 3,91% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $458.747.478 | 5.349.223 | 2,47% | Hisse senetleri |
| Invesco Ltd. | $342.626.146 | 3.979.860 | 1,84% | Hisse senetleri |
| PRIMECAP MANAGEMENT CO/CA/ | $328.577.983 | 3.816.680 | 1,77% | Hisse senetleri |
| VAN ECK ASSOCIATES CORP | $301.457.394 | 3.501.654 | 1,62% | Hisse senetleri |
| CITADEL ADVISORS LLC | $299.375.565 | 3.477.472 | 1,61% | Hisse senetleri |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $237.731.423 | 2.761.429 | 1,28% | Hisse senetleri |
| UBS Group AG | $237.489.165 | 2.758.615 | 1,28% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $236.270.951 | 2.744.463 | 1,27% | Hisse senetleri |
| MORGAN STANLEY | $223.102.705 | 2.591.503 | 1,20% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $187.480.282 | 2.177.724 | 1,01% | Hisse senetleri |
| NORTHERN TRUST CORP | $169.171.326 | 1.965.052 | 0,91% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $168.672.488 | 1.958.313 | 0,91% | Hisse senetleri |
| EQUITY INVESTMENT CORP | $144.748.296 | 1.681.360 | 0,78% | Hisse senetleri |
| NORGES BANK | $136.661.935 | 1.587.431 | 0,73% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $134.484.547 | 1.562.139 | 0,72% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $132.937.293 | 1.470.220 | 0,71% | Hisse senetleri |
| Legal & General Group Plc | $126.167.392 | 1.465.529 | 0,68% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $125.541.517 | 1.458.259 | 0,67% | Hisse senetleri |
| Vestal Point Capital, LP | $120.526.000 | 1.400.000 | 0,65% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $118.554.797 | 1.377.103 | 0,64% | Hisse senetleri |
| Holocene Advisors, LP | $101.367.617 | 1.177.461 | 0,54% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $99.065.937 | 1.150.725 | 0,53% | Hisse senetleri |
| Bank of New York Mellon Corp | $95.820.351 | 1.113.025 | 0,52% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $93.508.375 | 1.086.170 | 0,50% | Hisse senetleri |
| Camber Capital Management LP | $91.210.000 | 1.000.000 | 0,49% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $89.620.025 | 1.040.975 | 0,48% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $83.389.162 | 968.628 | 0,45% | Hisse senetleri |
| TORONTO DOMINION BANK | $81.590.162 | 947.731 | 0,44% | Hisse senetleri |
| Woodline Partners LP | $81.122.607 | 942.300 | 0,44% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $79.508.592 | 923.552 | 0,43% | Hisse senetleri |
| Point72 Asset Management, L.P. | $75.746.373 | 879.851 | 0,41% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $74.568.500 | 866.170 | 0,40% | Hisse senetleri |
| JPMORGAN CHASE & CO | $74.444.065 | 815.914 | 0,40% | Hisse senetleri |
| Sound Shore Management Inc /CT/ | $68.407.286 | 794.602 | 0,37% | Hisse senetleri |
| CAUSEWAY CAPITAL MANAGEMENT LLC | $67.908.650 | 788.810 | 0,37% | Hisse senetleri |
| Quantinno Capital Management LP | $62.169.005 | 722.139 | 0,33% | Hisse senetleri |
| Amundi | $61.922.729 | 719.279 | 0,33% | Hisse senetleri |
| Boston Partners | $61.088.392 | 709.202 | 0,33% | Hisse senetleri |
| Meridiem Capital Partners LP | $54.973.200 | 638.555 | 0,30% | Hisse senetleri |
| SHAPIRO CAPITAL MANAGEMENT LLC | $52.119.833 | 605.411 | 0,28% | Hisse senetleri |
| BANK OF MONTREAL /CAN/ | $49.368.266 | 573.449 | 0,27% | Hisse senetleri |
| Magellan Asset Management Ltd | $49.106.511 | 570.409 | 0,26% | Hisse senetleri |
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc., Honey Badger Merger Sub, Inc. | 15 Temmuz 2025 | 27,00% | İlk başvuru | M&A / satış | SEC |
| KKR Biomet LLC, KKR 2006 Fund L.P., OPERF Co-Investment LLC, KKR PEI Investments, L.P., 8 North America Investor L.P., KKR Partners III, L.P., KKR Associates 2006 LP, KKR 2006 GP LLC, KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Associates 8 NA L.P., KKR 8 NA Limited, KKR III GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts ×3 başvurular | 16 Haziran 2016 | · | İlk başvuru | · | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×3 başvurular | 16 Haziran 2016 | · | İlk başvuru | Sermaye yapısı | SEC |
| Blackstone Capital Partners V, L.P., Blackstone Capital Partners V-AC L.P., BCP V-S L.P., Blackstone Family Investment Partnership V L.P., Blackstone Family Investment Partnership V-SMD L.P., Blackstone Participation Partnership V L.P., BCP V Co-Investors L.P., Blackstone Management Associates V L.L.C., BMA V L.L.C., BCP V Side-By-Side GP L.L.C., Blackstone Family GP L.L.C., Blackstone Holdings III L.P., Blackstone Holdings III GP L.P., Blackstone Holdings III GP Management L.L.C., The Blackstone Group L.P., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×3 başvurular | 12 Şubat 2016 | · | İlk başvuru | · | SEC |
| LVB Acquisition Holding, LLC ×2 başvurular | 09 Şubat 2016 | · | İlk başvuru | · | SEC |
| Zimmer Holdings, Inc., Zimmer, Inc., Zimmer CEP USA Holding Co. ×3 başvurular | 10 Ağustos 2006 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 62 içeriden öğrenenler · 38 yöneticiler · 24 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Ivan Tornos | Chairman, President and CEO | 06 Mart 2026 M | 83.191 | 0 | 0 | $0 |
| Bryan C Hanson | President and CEO | 06 Mart 2023 A | 102.797 | 0 | 0 | $0 |
| John Raymond Elliott | Chairman, Pres. & CEO | 12 Şubat 2007 M | 62.751 | 0 | 0 | $0 |
| Suketu Upadhyay | Exec VP, CFO | 06 Mart 2026 M | 69.485 | 0 | 0 | $0 |
| Florin Daniel P | Exec. VP, CFO | 08 Mayıs 2019 G | 25.471 | 0 | 0 | $0 |
| James T Crines | EVP, Finance and CFO | 19 Mart 2015 M | 56.313 | 0 | 0 | $0 |
| Chintan Desai | President, APAC | 03 Ağustos 2026 A | · | 0 | 0 | $0 |
| Sang Yi | Group President, Asia Pacific | 29 Mayıs 2026 S | 27.251 | 0 | 3 | $-509.706 |
| Mark Bezjak | President, Americas | 06 Mart 2025 M | 13.134 | 0 | 0 | $0 |
| Didier Deltort | President, EMEA | 26 Şubat 2021 M | 4.619 | 0 | 0 | $0 |
| Aure Bruneau | Group President | 11 Kasım 2019 M | 757 | 0 | 0 | $0 |
| Robert D. Delp | President, Americas | 20 Mart 2018 A | · | 0 | 0 | $0 |
| David A. Nolan Jr. | Group President | 20 Mart 2018 A | 9.102 | 0 | 0 | $0 |
| Daniel E. Williamson | Group President | 20 Mart 2018 A | 2.000 | 0 | 0 | $0 |
| Adam Rudolph Johnson | Group President | 24 Haziran 2017 M | 11.093 | 0 | 0 | $0 |
| Stuart G. Kleopfer | President, Americas | 23 Ağustos 2016 S | 3.000 | 0 | 0 | $0 |
| Stephen H L Ooi | President, Asia Pacific | 19 Mart 2015 M | 45.411 | 0 | 0 | $0 |
| Joseph A. Cucolo | President, Americas | 01 Ekim 2014 M | 11.226 | 0 | 0 | $0 |
| Jon E Kramer | President, U.S. Sales | 12 Aralık 2008 M | 4.461 | 0 | 0 | $0 |
| Kevin R Thornal | Grp Pres-Global Business | 11 Eylül 2026 S | 0 | 0 | 1 | $-528.978 |
| Chad F Phipps | Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary | 04 Eylül 2026 S | 65.231 | 0 | 1 | $-295.050 |
| Jehanzeb Noor | Senior Vice President, Chief Strategy, Innovation & Business Development Officer | 01 Haziran 2026 A | 5.151 | 0 | 0 | $0 |
| Paul A Stellato | VP, Controller, CAO | 01 Mayıs 2026 A | 5.582 | 0 | 0 | $0 |
| Lori Winkler | SVP and CHRO | 12 Mart 2026 S | 10.224 | 0 | 1 | $-250.849 |
| Wilfred Van Zuilen | Group Pres, EMEA | 06 Mart 2026 M | 30.991 | 0 | 0 | $0 |
| Rachel Ellingson | Chief Administrative Officer | 20 Şubat 2025 M | 11.906 | 0 | 0 | $0 |
| Derek M Davis | Interim Controller & CAO | 01 Mart 2022 A | 6.809 | 0 | 0 | $0 |
| Carrie Ann Nichol | VP, Controller & CAO | 01 Ekim 2021 M | 338 | 0 | 0 | $0 |
| Tony W. Collins | VP, Controller and CAO | 31 Temmuz 2018 M | 368 | 0 | 0 | $0 |
| Katarzyna Mazur-Hofsaess | Pres., Eur., M. East & Afr. | 22 Mayıs 2018 M | 16.682 | 0 | 0 | $0 |
| Jeffery A Mccaulley | Pres - Zimmer Reconstructive | 08 Ocak 2014 M | 5.211 | 0 | 0 | $0 |
| Jeffrey B Paulsen | Group Pres., Global Businesses | 16 Mart 2013 M | 6.095 | 0 | 0 | $0 |
| Cheryl R Blanchard | Sr. VP, Chief Scientific Off. | 19 Mart 2012 A | 18.357 | 0 | 0 | $0 |
| Mark C Throdahl | Group Pres - Global Business | 12 Haziran 2009 D | 844 | 0 | 0 | $0 |
| Sheryl L Conley | Group Pres., Americas & Mktg. | 12 Şubat 2008 A | 2.559 | 0 | 0 | $0 |
| Sam R Leno | EVP | 04 Mayıs 2007 D | 27.513 | 0 | 0 | $0 |
| Richard Fritschi | Pres. Zimmer Europe & Austral. | 18 Ocak 2005 A | · | 0 | 0 | $0 |
| Bruce Edward Peterson | Chairman, Zimmer Americas | 17 Mart 2004 M | 17.975 | 0 | 0 | $0 |
| Louis Shapiro | Yönetim kurulu üyesi | 30 Eylül 2026 A | · | 0 | 0 | $0 |
| Devdatt Kurdikar | Yönetim kurulu üyesi | 30 Eylül 2026 A | · | 0 | 0 | $0 |
| Sreelakshmi Kolli | Yönetim kurulu üyesi | 30 Eylül 2026 A | 1.000 | 0 | 0 | $0 |
| Maria Teresa Hilado | Yönetim kurulu üyesi | 30 Eylül 2026 A | 1.650 | 0 | 0 | $0 |
| Michael J. Farrell | Yönetim kurulu üyesi | 30 Eylül 2026 A | 2.000 | 0 | 0 | $0 |
| Robert Hagemann | Yönetim kurulu üyesi | 30 Eylül 2026 A | 4.000 | 0 | 0 | $0 |
| HIGGINS ARTHUR J | Yönetim kurulu üyesi | 30 Eylül 2026 A | 3.400 | 0 | 0 | $0 |
| Syed A. Jafry | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 4.060 | 0 | 0 | $0 |
| Betsy J Bernard | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 5.271 | 0 | 0 | $0 |
| Christopher B Begley | Yönetim kurulu üyesi | 31 Mart 2025 A | 3.540 | 0 | 0 | $0 |
| Michael W Michelson | Yönetim kurulu üyesi | 10 Mayıs 2024 A | 3.385 | 0 | 0 | $0 |
| Gail Boudreaux | Yönetim kurulu üyesi | 31 Mart 2021 A | 2.095 | 0 | 0 | $0 |
| Larry C Glasscock | Yönetim kurulu üyesi | 08 Mayıs 2020 A | 10.861 | 0 | 0 | $0 |
| Jeffrey K. Rhodes | Yönetim kurulu üyesi | 31 Mart 2018 A | · | 0 | 0 | $0 |
| Cecil B Pickett | Yönetim kurulu üyesi | 12 Mayıs 2017 A | · | 0 | 0 | $0 |
| Paul Bisaro | Yönetim kurulu üyesi | 31 Mart 2017 A | · | 0 | 0 | $0 |
| John L Mcgoldrick | Yönetim kurulu üyesi | 07 Mayıs 2013 A | 11.332 | 0 | 0 | $0 |
| Marc N Casper | Yönetim kurulu üyesi | 31 Mart 2013 A | · | 0 | 0 | $0 |
| Augustus A White | Yönetim kurulu üyesi | 03 Mayıs 2010 A | 0 | 0 | 0 | $0 |
| Stuart Essig | Yönetim kurulu üyesi | 05 Mayıs 2008 A | · | 0 | 0 | $0 |
| Regina E Herzlinger | Yönetim kurulu üyesi | 02 Mayıs 2005 A | 40 | 0 | 0 | $0 |
| David C Dvorak | · | 27 Nisan 2017 M | 294.555 | 0 | 0 | $0 |
| LVB Acquisition Holding, LLC | · | 04 Şubat 2016 J | 0 | 0 | 0 | $0 |
| Bruno A Melzi | · | 16 Mart 2013 M | 11.005 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 119 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IHI · iShares Trust | 2,69% | 924.883 SH | 11 Eylül 2026 | Günlük |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,47% | 275.654 NS | 31 Temmuz 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,54% | 152.036 SH | 02 Ekim 2026 | Günlük |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,94% | 139.642 NS | 31 Temmuz 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,94% | 4.287 NS | 31 Temmuz 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,49% | 81.838 NS | 31 Temmuz 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,47% | 5.916 NS | 31 Temmuz 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,47% | 8.435 NS | 31 Temmuz 2026 | N-PORT |
| SOVF · Elevation Series Trust | 0,41% | 3.781 NS | 31 Temmuz 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0,40% | 2.152 NS | 31 Temmuz 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,34% | 64.683 SH | 02 Ekim 2026 | Günlük |
| IYH · iShares Trust | 0,29% | 113.463 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,26% | 91.889 NS | 31 Temmuz 2026 | N-PORT |
| IMCV · iShares Trust | 0,25% | 31.505 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,25% | 581.880 SH | 19 Ağustos 2026 | Günlük |
| REVS · Columbia ETF Trust I | 0,24% | 8.508 NS | 31 Temmuz 2026 | N-PORT |
| IXJ · iShares Trust | 0,23% | 101.995 SH | 11 Eylül 2026 | Günlük |
| SIZE · iShares Trust | 0,21% | 9.696 SH | 11 Eylül 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,21% | 3.807 NS | 31 Temmuz 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0,19% | 6.205 NS | 31 Temmuz 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 2.063.000 SH | 02 Ekim 2026 | Günlük |
| EUSA · iShares, Inc. | 0,19% | 38.732 SH | 11 Eylül 2026 | Günlük |
| VLUE · iShares Trust | 0,18% | 191.362 SH | 11 Eylül 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | 0,18% | 1.408.631 SH | 19 Ağustos 2026 | Günlük |
| IWS · iShares Trust | 0,18% | 289.171 SH | 11 Eylül 2026 | Günlük |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,16% | 220.000 | 02 Ekim 2026 | Günlük |
| RECS · Columbia ETF Trust I | 0,16% | 96.586 NS | 31 Temmuz 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 13.402 NS | 31 Temmuz 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,15% | 15.020 SH | 19 Ağustos 2026 | Günlük |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,15% | 4.099.000 | 02 Ekim 2026 | Günlük |
| VOE · VANGUARD INDEX FUNDS | 0,14% | 621.372 SH | 19 Ağustos 2026 | Günlük |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,14% | 6.247.000 | 01 Ekim 2026 | Günlük |
| IWR · iShares Trust | 0,13% | 792.254 SH | 11 Eylül 2026 | Günlük |
| IMCB · iShares Trust | 0,12% | 22.655 SH | 11 Eylül 2026 | Günlük |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 4.049.000 | 01 Ekim 2026 | Günlük |
| XOEF · iShares Trust | 0,10% | 248 SH | 11 Eylül 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.218.373 SH | 19 Ağustos 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 8.178 SH | 02 Ekim 2026 | Günlük |
| CATH · Global X Funds | 0,09% | 11.989 NS | 31 Temmuz 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,08% | 2.097.251 SH | 19 Ağustos 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 8.286 SH | 02 Ekim 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,07% | 118.337 NS | 31 Temmuz 2026 | N-PORT |
| USXF · iShares Trust | 0,07% | 11.458 SH | 11 Eylül 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 70.147 SH | 02 Ekim 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,06% | 14.595 NS | 31 Temmuz 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,06% | 44.339 SH | 19 Ağustos 2026 | Günlük |
| IVE · iShares Trust | 0,06% | 321.014 SH | 11 Eylül 2026 | Günlük |
| IUSV · iShares Trust | 0,06% | 168.895 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,06% | 3.302 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,06% | 284.411 NS | 31 Temmuz 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,06% | 1.943 NS | 31 Temmuz 2026 | N-PORT |
| CHRI · Global X Funds | 0,06% | 47 NS | 31 Temmuz 2026 | N-PORT |
| ILCV · iShares Trust | 0,05% | 7.599 SH | 11 Eylül 2026 | Günlük |
| SUSL · iShares Trust | 0,05% | 6.763 SH | 11 Eylül 2026 | Günlük |
| DSI · iShares Trust | 0,05% | 29.825 SH | 11 Eylül 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 116.793 SH | 19 Ağustos 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,05% | 17.680 NS | 31 Temmuz 2026 | N-PORT |
| IWD · iShares Trust | 0,05% | 429.649 SH | 11 Eylül 2026 | Günlük |
| EGLE · Global X Funds | 0,04% | 10 NS | 31 Temmuz 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,04% | 5 NS | 31 Temmuz 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,04% | 44.794 SH | 02 Ekim 2026 | Günlük |
| DFLV · Dimensional ETF Trust | 0,03% | 24.552 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,03% | 45.016 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 0,03% | 226 NS | 31 Temmuz 2026 | N-PORT |
| TOPC · iShares Trust | 0,03% | 117 SH | 11 Eylül 2026 | Günlük |
| XCLR · Global X Funds | 0,03% | 12 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,03% | 163 NS | 31 Temmuz 2026 | N-PORT |
| XVV · iShares Trust | 0,03% | 2.222 SH | 11 Eylül 2026 | Günlük |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,03% | 5.778 SH | 02 Ekim 2026 | Günlük |
| VOO · VANGUARD INDEX FUNDS | 0,03% | 5.022.961 SH | 19 Ağustos 2026 | Günlük |
| VTV · VANGUARD INDEX FUNDS | 0,03% | 920.066 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,03% | 43.771 SH | 19 Ağustos 2026 | Günlük |
| TOV · EA Series Trust | 0,03% | 921 NS | 31 Temmuz 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,03% | 17.261 NS | 31 Temmuz 2026 | N-PORT |
| XYLD · Global X Funds | 0,03% | 10.147 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,03% | 10.046 NS | 31 Temmuz 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 26.677 NS | 31 Temmuz 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,03% | 3.273 NS | 31 Temmuz 2026 | N-PORT |
| ILCB · iShares Trust | 0,03% | 3.851 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,03% | 60.829 NS | 31 Temmuz 2026 | N-PORT |
| IVV · iShares Trust | 0,03% | 2.438.768 SH | 11 Eylül 2026 | Günlük |
| XTR · Global X Funds | 0,03% | 14 NS | 31 Temmuz 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,03% | 1.142 SH | 02 Ekim 2026 | Günlük |
| SPUU · Direxion Shares ETF Trust | 0,03% | 730 NS | 31 Temmuz 2026 | N-PORT |
| IYY · iShares Trust | 0,03% | 8.407 SH | 11 Eylül 2026 | Günlük |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,03% | 33.488 SH | 02 Ekim 2026 | Günlük |
| IWB · iShares Trust | 0,03% | 133.637 SH | 11 Eylül 2026 | Günlük |
| QDPL · Pacer Funds Trust | 0,03% | 4.637 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,03% | 54.548 SH | 11 Eylül 2026 | Günlük |
| USCL · iShares Trust | 0,03% | 7.635 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,02% | 251.793 SH | 11 Eylül 2026 | Günlük |
| HCMT · Direxion Shares ETF Trust | 0,02% | 1.351 NS | 31 Temmuz 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,02% | 350 NS | 31 Temmuz 2026 | N-PORT |
| TOK · iShares Trust | 0,02% | 545 SH | 11 Eylül 2026 | Günlük |
| SPXL · Direxion Shares ETF Trust | 0,02% | 15.123 NS | 31 Temmuz 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,02% | 143 SH | 02 Ekim 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 6.142.505 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31.872 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 16.297 SH | 19 Ağustos 2026 | Günlük |
| URTH · iShares, Inc. | 0,02% | 17.242 SH | 11 Eylül 2026 | Günlük |
| VOXP · Advisors Series Trust | 0,02% | 12 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 4.266 NS | 31 Temmuz 2026 | N-PORT |
| ACWI · iShares Trust | 0,02% | 64.570 SH | 11 Eylül 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,02% | 23.873 NS | 31 Temmuz 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 5.624 SH | 02 Ekim 2026 | Günlük |
| VV · VANGUARD INDEX FUNDS | 0,01% | 113.321 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 168.446 SH | 19 Ağustos 2026 | Günlük |
| DYNF · BlackRock ETF Trust | 0,00% | 80 SH | 02 Eylül 2026 | Günlük |
| FTLS · First Trust Exchange-Traded Fund III | -0,18% | -46.926 NS | 31 Temmuz 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Temmuz 2026 | Günlük |
ZBH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 33 analist
TUT
Medyan hedef
$106.00
+20,1%
3 9,1%
Güçlü Al
8 24,2%
Al
22 66,7%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
21 analist · 2026-09-29Ortalama hedef $107.57 +21,8%
← Tüm hedeflerin altında
Mevcut fiyat $88.29
Düşük$93.00
Ortalama$107.57
Yüksek$130.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
Son Haberler Bu şirketten bahseden son manşetler
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Şu anda açık sinyal yok — hiçbir kart dolu değil ve bu dürüstçe.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026